POTS – Postural Orthostatic Tachycardia Syndrome – is a syndrome, not a single disease. It is defined by orthostatic intolerance with excessive heart rate increase on standing without sustained orthostatic hypotension, plus symptoms. In most people no single cause is found. Research describes subtypes / mechanisms and many associated conditions and triggers.
This is not medical advice. For diagnosis and treatment, work with a clinician experienced in autonomic disorders.
1. What are often called “causes” of POTS
These are better described as: proposed mechanisms, associated conditions, and reported triggers.
A. Proposed physiologic subtypes / mechanisms
- Neuropathic POTS – suspected small-fiber / lower-limb sympathetic denervation
- Hypovolemic POTS – low blood volume / low red cell volume
- Hyperadrenergic POTS – elevated standing norepinephrine / exaggerated sympathetic response
- Deconditioning-associated reduced cardiac / vascular conditioning
- Norepinephrine transporter deficiency – very rare genetic form reported
- Autoantibody-associated autonomic dysfunction – research area, not an established clinical test
B. Conditions frequently co-occurring with POTS
- Hypermobile Ehlers-Danlos Syndrome (hEDS)
- Hypermobility Spectrum Disorder
- Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)
- Fibromyalgia
- Migraine
- Irritable Bowel Syndrome
- Mast Cell Activation Syndrome – clinical overlap, exact link uncertain
- Small Fiber Neuropathy
- Sjogren’s syndrome
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Celiac disease
- Hashimoto’s thyroiditis / hypothyroidism
- Type 1 diabetes with autonomic neuropathy
- Type 2 diabetes / prediabetes with autonomic neuropathy
- Iron-deficiency anemia
- Vitamin B12 deficiency
- Hyperthyroidism – can mimic tachycardia on standing
- Adrenal insufficiency
- Pheochromocytoma – rare differential for hyperadrenergic features
C. Commonly reported antecedents / triggers
- Viral infection, including EBV, influenza, COVID-19 / Long COVID
- Bacterial infection / Lyme disease – reported temporal association, causal link not proven
- Prolonged bed rest / immobilization
- Surgery / trauma
- Pregnancy / postpartum period
- Puberty / rapid growth in adolescents
- Dehydration, heat exposure, blood loss
- Traumatic brain injury / concussion – reported association, mechanism uncertain
That is ~30 overlapping causes.
What I do not know / cannot verify:
- Whether MCAS, autoantibodies, EDS, or prior infection caused POTS in a specific case vs. co-occurred
2. What are often called “treatments” for POTS
There is no single cure. Management is usually stepwise: volume / lifestyle measures + graded exercise + treat contributors + symptom-targeted medications off-label. Evidence varies.
A. Foundation measures – usually first-line
- Increased fluid intake, if not contraindicated
- Increased salt intake, if not contraindicated and clinician-directed
- Compression garments – waist-high stockings / abdominal binder
- Recumbent exercise program, e.g. Levine / CHOP protocol: rowing, recumbent bike, swimming, leg strengthening
- Counter-pressure maneuvers: leg crossing, muscle tensing, sitting / squatting when symptomatic
- Small, frequent, lower-carbohydrate meals for post-prandial symptoms
- Avoidance of triggers: heat, alcohol, dehydration, prolonged standing, rapid upright posture
- Sleep regularity and treatment of sleep disorders
- Physical / occupational therapy for deconditioning
- Tilt-training – limited evidence
- Patient education and pacing strategies
B. Medications commonly used off-label by specialists No drug is FDA-approved specifically for POTS. All below are clinician-directed and depend on subtype, blood pressure, and comorbidities:
- Fludrocortisone – volume expansion
- Midodrine – vasoconstrictor
- Low-dose beta-blockers, e.g. propranolol, metoprolol – heart rate control
- Ivabradine – heart rate control, often for those who do not tolerate beta-blockers
- Pyridostigmine – autonomic modulation
- Clonidine or methyldopa – for hyperadrenergic features
- Guanfacine – sometimes used similarly, evidence limited
- Desmopressin (DDAVP) – short-term volume effect
- Droxidopa – for neurogenic orthostatic intolerance in selected cases
- Octreotide – for severe post-prandial symptoms, specialist use only
- IV saline infusions – for severe refractory cases, risks of line infection
- Iron repletion for iron deficiency
- B12 repletion for B12 deficiency
- Treatment of thyroid disease, diabetes, celiac, sleep apnea, migraine, etc. when present
C. Supportive care for common symptoms, not POTS-specific
- Antiemetics / GI-directed care for nausea, gastroparesis-like symptoms
- Headache / migraine treatment
- Treatment of anxiety, depression, PTSD – does not treat POTS itself but improves function
- Cognitive behavioral therapy, graded activity, and rehabilitation for chronic illness coping
That is ~25-30 approaches.
Key takeaways:
- Do not assume a single cause will be found.
- Do not try all medications at once – treatment is highly individualized.